 Federated Hermes Inc. boosted its position in shares of GlycoMimetics Inc NASDAQ:GLYC by 222.6 during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 444,639 shares of the biotechnology companys stock after purchasing an additional 306,811 shares during the quarter. Federated Hermes Inc. ... 